
News from Atom Bioscience
16 October, 2023
PRESS RELEASE
Atom Bioscience Raises $83M in a D-Round Financing to Support Global Pivotal Clinical Trials...
09 October, 2023
Atom Bioscience Doses First Patient in Phase 2b/3 Clinical Trial of a New Treatment for Chronic Gout
PRESS RELEASE
Atom Bioscience Doses First Patient in Phase 2b/3 Clinical Trial of a New Treatment for...
22 May, 2023
PRESS RELEASE
Atom Bioscience Marks Gout Awareness Day by Urging Increased Patient Education on Debilitating...
03 April, 2023
PRESS RELEASE
Atom Bioscience Names UC San Diego Professor Robert Terkeltaub, M.D., to its Scientific...
01 March, 2023
PRESS RELEASE
Atom Bioscience Announces Positive Results of Phase 2a China Clinical Trial of Its URAT1...
01 February, 2023
PRESS RELEASE
Atom Bioscience to Present at BIO CEO & Investor Conference on February 6, 2023, at...
25 January, 2023
PRESS RELEASE
Atom Bioscience Names Stanford University Professor Vibeke Strand, M.D., to its Scientific...
10 November, 2022
PRESS RELEASE
Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic...
13 September, 2022
PRESS RELEASE
Atom Bioscience Announces Abstract for Its Phase 2a Gout Study Accepted for American College...
08 June, 2022
PRESS RELEASE
Atom Bioscience to Update Clinical Development of New Drug to Treat Gout at BIO International...